Browsing: Pharma

After hinting at expanding plasma-based manufacturing in the U.S. late last year, CSL is moving…

Nearly five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy…

Emma Walmsley leaves on a high note after nearly nine years as GSK’s CEO, with…

The FDA is doubling down on its goal of increasing the availability of biosimilar drugs…

Eli Lilly defended its CEO David Rix’s $36.7 million compensation shortly before filing a proxy…

Hims & Hers and Novo Nordisk have officially put down swords. After years of public…

In a whirlwind seven-month period in 2022, Bristol-Myers Squibb received FDA approval for three new…

Issues at the former Catalent plant, now owned by Novo Nordisk, derailed another FDA application,…

Ipsen is halting sales of its cancer drug Tazveric, which it acquired through its acquisition…

Dr. Alan J. Balch, CEO, Patient Advocacy Foundation | Incoming Executive Chairman of the Patient…